Title of article
Aortic root replacement in adolescents and young adults: composite graft versus homograft or autograft
Author/Authors
Giovanni Battista Luciani، نويسنده , , Gianluca Casali، نويسنده , , Francesco Santini، نويسنده , , Alessandro Mazzucco، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1998
Pages
5
From page
189
To page
193
Abstract
Background. Aortic root replacement (ARR) is a technically demanding procedure that can be performed using a variety of prosthetic devices. Root replacement in the young, but grown-up, patient poses unique problems in terms of the long-term outcome and active lifestyle that must be guaranteed by this operation. To identify the “ideal” substitute for ARR in the young, clinical results in teenagers and young adults (<35 years) operated on in the past two decades were reviewed.
Methods. Thirty-eight patients younger than 35 years underwent ARR between January 1980 and December 1996. Eighteen patients, aged 30 ± 5 years, had ARR with composite graft (group 1), whereas 20 patients, aged 28 ± 6 years, had ARR with aortic homografts or pulmonary autografts (group 2). Primary indication for the operation was aortic insufficiency with anuloaortic ectasia (12 of 18) in group 1 and aortic insufficiency with or without anuloaortic ectasia (16 of 20) in group 2. Urgent ARR was required in 3 (17%) group 1 patients and 1 (5%) group 2 patient (p = 0.01).
Results. Operative deaths were 2 (11%) in group 1, caused by hemorrhage and low output, and none in group 2. There were 4 (25%) late deaths in group 1, caused by embolism (2), hemorrhage, and myocardial infarction, and 1 (5%) in group 2, caused by arrhythmia. Survival was 81% ± 9%, and 55% ± 18% at 2 and 10 years in group 1 versus 94% ± 5% at 2 years in group 2 (p = 0.04). Freedom from valve-related events was 93% ± 6% and 62% ± 18% at 2 and 10 years in group 1 versus 100% at 2 years in group 2 (p = 0.02). Freedom from reoperation in group 1 was 75% ± 22% at 10 years, whereas no reoperations were done in group 2. Seven (58%) group 1 patients versus 1 (5%) group 2 patient were on cardiac medications (p = 0.001), and 11 (92%) group 1 patients versus no group 2 patients were on warfarin therapy at follow-up. All survivors were back to school or prior employment.
Conclusions. Survival early after ARR does not differ depending on the type of prosthesis. Valve-related events are common, and reoperation may be needed late after ARR with composite grafts. Despite limited follow-up with biologic devices, the prevalence of complications with composite grafts makes homograft or autograft ARR preferable in adolescents and young adults.
Journal title
The Annals of Thoracic Surgery
Serial Year
1998
Journal title
The Annals of Thoracic Surgery
Record number
615538
Link To Document